Johnson & Johnson is gearing up to test a HIV vaccine in a 3,800-person clinical trial. The preparations follow animal studies that showed the vaccine offered better protection than earlier attempts to confer immunity to the virus.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,